Daniel L. Worthley

2.2k total citations
19 papers, 1.1k citations indexed

About

Daniel L. Worthley is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Daniel L. Worthley has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 5 papers in Surgery. Recurrent topics in Daniel L. Worthley's work include Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Screening and Detection (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Daniel L. Worthley is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Screening and Detection (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Daniel L. Worthley collaborates with scholars based in Australia, United States and United Kingdom. Daniel L. Worthley's co-authors include Barbara Leggett, Graeme P. Young, Kerry Phillips, Graeme Suthers, Igor Matić, Brya G. Matthews, Ivo Kalajzić, Nathaniel A. Dyment, Danka Grčević and Xi Wang and has published in prestigious journals such as Gastroenterology, Gut and International Journal of Cancer.

In The Last Decade

Daniel L. Worthley

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Worthley Australia 15 527 455 399 241 232 19 1.1k
Cristina Oliani Italy 15 771 1.5× 457 1.0× 212 0.5× 377 1.6× 157 0.7× 37 1.1k
Hanna Rennert United States 14 248 0.5× 218 0.5× 462 1.2× 205 0.9× 214 0.9× 25 1.0k
Johan A. Offerhaus Netherlands 12 701 1.3× 659 1.4× 254 0.6× 345 1.4× 448 1.9× 17 1.3k
Wolfgang M. Brueckl Germany 21 749 1.4× 266 0.6× 329 0.8× 177 0.7× 124 0.5× 60 1.2k
Jianhui Shi United States 20 482 0.9× 142 0.3× 355 0.9× 211 0.9× 426 1.8× 39 1.2k
Mara Fornasarig Italy 20 787 1.5× 817 1.8× 253 0.6× 361 1.5× 434 1.9× 55 1.4k
Alexandra M. J. Langers Netherlands 18 375 0.7× 254 0.6× 174 0.4× 167 0.7× 235 1.0× 62 826
Noreen Fulton United States 20 460 0.9× 304 0.7× 457 1.1× 141 0.6× 192 0.8× 42 1.2k
Hajime Kuroda Japan 16 380 0.7× 231 0.5× 167 0.4× 212 0.9× 118 0.5× 53 808

Countries citing papers authored by Daniel L. Worthley

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Worthley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Worthley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Worthley more than expected).

Fields of papers citing papers by Daniel L. Worthley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Worthley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Worthley. The network helps show where Daniel L. Worthley may publish in the future.

Co-authorship network of co-authors of Daniel L. Worthley

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Worthley. A scholar is included among the top collaborators of Daniel L. Worthley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Worthley. Daniel L. Worthley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhao, Shuai, Peng Yao, Shardul Bhilocha, et al.. (2020). Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation. Mucosal Immunology. 13(4). 665–678. 42 indexed citations
2.
Duan, Meng, Junfeng Hao, Sijia Cui, et al.. (2018). Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing. Cell Research. 28(3). 359–373. 97 indexed citations
3.
Matić, Igor, Brya G. Matthews, Xi Wang, et al.. (2016). Quiescent Bone Lining Cells Are a Major Source of Osteoblasts During Adulthood. Stem Cells. 34(12). 2930–2942. 131 indexed citations
4.
Biswas, Sujata, Hayley L. Belnoue-Davis, Shazia Irshad, et al.. (2015). Microenvironmental control of stem cell fate in intestinal homeostasis and disease. The Journal of Pathology. 237(2). 135–145. 53 indexed citations
5.
Miranda, Mariska, Daniel L. Worthley, Kazutomo Togashi, et al.. (2014). The CIMP Phenotype inBRAFMutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort. Gastroenterology Research and Practice. 2014. 1–10. 39 indexed citations
6.
Worthley, Daniel L., Kerry Phillips, Kasmintan A. Schrader, et al.. (2011). Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 61(5). 774–779. 171 indexed citations
7.
Whitehall, Vicki, Catherine Bond, Sonia A. Greco, et al.. (2011). Oncogenic PIK3CA mutations in colorectal cancers and polyps. International Journal of Cancer. 131(4). 813–820. 69 indexed citations
8.
Spring, Kevin J., et al.. (2010). Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer. 10(1). 494–494. 45 indexed citations
9.
Hewett, David G., Daniel L. Worthley, Ron Buttenshaw, et al.. (2010). Hyperplastic Polyposis Syndrome Is Associated With Cigarette Smoking, Which May Be a Modifiable Risk Factor. The American Journal of Gastroenterology. 105(7). 1642–1647. 22 indexed citations
10.
Worthley, Daniel L. & Barbara Leggett. (2010). Colorectal cancer: molecular features and clinical opportunities.. PubMed. 31(2). 31–8. 136 indexed citations
11.
Worthley, Daniel L., Vicki Whitehall, Ron Buttenshaw, et al.. (2009). 199 DNA Methylation Throughout the Normal Human Colorectum: Evidence of An Epigenetic Field Effect. Gastroenterology. 136(5). A–37. 2 indexed citations
12.
Worthley, Daniel L., et al.. (2008). SLC5A8 methylation, CIMP and BRAF mutation in serrated polyps of the colorectum. Journal of Gastroenterology and Hepatology. 23. 1 indexed citations
13.
Worthley, Daniel L., Graeme Suthers, & Lara Lipton. (2008). Management of MUTYH‐associated neoplasia in Australia. Internal Medicine Journal. 38(8). 644–650. 1 indexed citations
14.
Worthley, Daniel L.. (2007). Colorectal carcinogenesis: Road maps to cancer. World Journal of Gastroenterology. 13(28). 3784–3784. 101 indexed citations
15.
LaPointe, Lawrence C., Robert Dunne, Daniel L. Worthley, et al.. (2007). Map of differential transcript expression in the normal human large intestine. Physiological Genomics. 33(1). 50–64. 73 indexed citations
16.
Worthley, Daniel L., Stephen R. Cole, Adrian Esterman, et al.. (2006). Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Internal Medicine Journal. 36(9). 607–610. 59 indexed citations
17.
Worthley, Daniel L., Michael D. Walsh, Melissa Barker, et al.. (2005). Familial Mutations in PMS2 Can Cause Autosomal Dominant Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 128(5). 1431–1436. 56 indexed citations
18.
Worthley, Daniel L., David Gillis, Frank Kette, & William Smith. (2005). Radiocontrast anaphylaxis with failure of premedication. Internal Medicine Journal. 35(1). 58–60. 14 indexed citations
19.
Worthley, Daniel L., et al.. (2004). Seroquel, Serzone and seizures. Internal Medicine Journal. 34(3). 134–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026